Congress 117 - HR 5585 - ARPA–H Act

Sponsor

Cosponsors

Topics

Advisory bodies Department of Health and Human Services Drug safety, medical device, and laboratory regulation Executive agency funding and structure Federal officials Government information and archives Government studies and investigations Health Health care costs and insurance Health technology, devices, supplies Public contracts and procurement Research administration and funding Research and development Technology transfer and commercialization

Full Text

View Full Bill Text

Votes

Summary

Advanced Research Projects Agency-Health Act or the ARPA-H Act

This bill establishes within the Department of Health and Human Services (HHS) the Advanced Research Projects Agency-Health to accelerate health and medical innovation by investing in high-risk, high-reward research. The bill also establishes a committee to advise on agency activities.

HHS must transfer all authorities, functions, funds, and personnel from a similar entity within the National Institutes of Health to a new, independent agency.

Additionally, the President must appoint a director to lead the agency. The director may submit testimony and recommendations concerning the agency to Congress without review or approval by other federal officers or agencies.

The director must appoint personnel to administer the agency's research programs, including by selecting projects to support and making recommendations about terminating or continuing projects.

The agency may use grants, prize competitions, and a variety of other mechanisms to support the research projects. The agency's budget is separate from that of HHS.

The agency must coordinate with the Food and Drug Administration and the Centers for Medicare & Medicaid Services to expedite development and coverage of high-need cures. Additionally, the agency may partner with other public and private entities (e.g., institutions of higher education and patient advocacy organizations).

The bill also requires the agency to develop and periodically update a strategic plan and annually report on its activities. Furthermore, (1) the National Academies of Sciences, Engineering, and Medicine must evaluate the agency's performance; and (2) the Government Accountability Office must review the research portfolio of HHS and its components, including the new agency.

Actions

Jun 23, 2022

Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Jun 22, 2022

Motion to reconsider laid on the table Agreed to without objection.
Jun 22, 2022

On passage Passed by the Yeas and Nays: 336 - 85 (Roll no. 288).
Jun 22, 2022

Passed/agreed to in House: On passage Passed by the Yeas and Nays: 336 - 85 (Roll no. 288).
Jun 22, 2022

Considered as unfinished business. (consideration: CR H5808-5809)
Jun 22, 2022

Pursuant to clause 1(c) of rule XIX, the Chair announced that further proceedings on H.R. 5585 would resume.
Jun 22, 2022

Pursuant to clause 1(c) of rule XIX, the Chair announced that further proceedings on H.R. 5585 would be postponed.
Jun 22, 2022

POSTPONED PROCEEDINGS - At the conclusion of debate on the Eshoo amendment, the Chair put the question on adoption of the amendment and by voice vote, announced that the ayes had prevailed. Mrs. Boebert demanded the yeas and nays and the Chair postponed further proceedings until a time to be announced.
Jun 22, 2022

DEBATE - Pursuant to the provisions of H. Res. 1170, the House proceeded with 10 minutes of debate on the Eshoo amendment No. 1.
Jun 22, 2022

DEBATE - The House proceeded with one hour of debate on H.R. 5585.
Jun 22, 2022

Rule provides for consideration of H.R. 4176, H.R. 5585 and H.R. 7666. Rule provides for one hour of general debate on H.R. 4176, H.R. 5585 and H.R. 7666. Rule provides for one motion to recommit each for H.R. 4176, H.R. 5585 and H.R. 7666. Rule provides that proceedings may be postponed through July 15, 2022, on measures that were the object of motions to suspend the rules on the legislative days of June 21, 2022, June 22, 2022, June 23, 2022, or June 24, 2022, and on which the yeas and nays were ordered.
Jun 22, 2022

Considered under the provisions of rule H. Res. 1191. (consideration: CR H5795-5803; text: CR H5795-5798)
Jun 21, 2022

Rules Committee Resolution H. Res. 1191 Reported to House. Rule provides for consideration of H.R. 4176, H.R. 5585 and H.R. 7666. Rule provides for one hour of general debate on H.R. 4176, H.R. 5585 and H.R. 7666. Rule provides for one motion to recommit each for H.R. 4176, H.R. 5585 and H.R. 7666. Rule provides that proceedings may be postponed through July 15, 2022, on measures that were the object of motions to suspend the rules on the legislative days of June 21, 2022, June 22, 2022, June 23, 2022, or June 24, 2022, and on which the yeas and nays were ordered.
Jun 13, 2022

Placed on the Union Calendar, Calendar No. 277.
Jun 13, 2022

Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 117-365.
May 18, 2022

Ordered to be Reported (Amended) by the Yeas and Nays: 53 - 3.
May 18, 2022

Committee Consideration and Mark-up Session Held.
May 11, 2022

Forwarded by Subcommittee to Full Committee by Voice Vote .
May 11, 2022

Subcommittee Consideration and Mark-up Session Held.
Oct 18, 2021

Referred to the Subcommittee on Health.
Oct 15, 2021

Referred to the House Committee on Energy and Commerce.
Oct 15, 2021

Introduced in House

Amendments

Related Bills